Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 61)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A MRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
24-Nov-09 Pechala's Reports Lubomir Pechala MEDICIS PHARMACEUTICAL CORPORATION (MRX=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
24-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (MRX). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (MRX). 5 $18 View Abstract
23-Nov-09 Reuters Investment Profile N/A Medicis Pharmaceutical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Reuters Investment Profile N/A Metalrax Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MRX 13 $25 View Abstract
23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 15)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
11-Nov-09 Thomson StreetEvents N/A MRX - Event Transcript of Medicis conference call, Nov. 11, 2009 / 12:30pm ET 7 $75 View Abstract
7-Nov-09 Thomson StreetEvents N/A MRX - Event Transcript of Medicis conference call, Nov. 04, 2009 / 5:15pm ET 18 $75 View Abstract
5-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 25 $75 View Abstract
5-Nov-09 Collins Stewart LLC Louise Chen Quality 3Q09 Beat, Focus on Dysport Launch, Solodyn and Pipeline 13 $50 View Abstract
5-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Q3 beats on marginal quality 6 $25 View Abstract
2-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50 View Abstract
2-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Solodyn Tracker: Week ending 10/23/2009 10 $25 View Abstract
23-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 19 $50 View Abstract
22-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Solodyn Tracker: Week Ending 10/9/2009 10 $25 View Abstract
16-Oct-09 Collins Stewart LLC Louise Chen November 2009 Stock Catalysts 22 $75 View Abstract
Next 5

Independent Reports (Showing 1 to 10 of 46)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A MRX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
24-Nov-09 Pechala's Reports Lubomir Pechala MEDICIS PHARMACEUTICAL CORPORATION (MRX=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
24-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (MRX). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (MRX). 5 $18 View Abstract
23-Nov-09 Reuters Investment Profile N/A Medicis Pharmaceutical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Reuters Investment Profile N/A Metalrax Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MRX 13 $25 View Abstract
23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.